# Pneumonia Vaccine in Aging HIV Positive Individuals

> **NCT02558751** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Toledo Health Science Campus** · enrollment: 51 (actual)

## Conditions studied

- Pneumococcal Infection

## Interventions

- **BIOLOGICAL:** 23-valent pneumococcal polysaccharide vaccine
- **BIOLOGICAL:** 13-valent pneumococcal conjugate vaccine

## Key facts

- **NCT ID:** NCT02558751
- **Lead sponsor:** University of Toledo Health Science Campus
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2015-09-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02558751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02558751, "Pneumonia Vaccine in Aging HIV Positive Individuals". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT02558751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*